World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
48
Citations
11686
World Ranking
4640
National Ranking
1793

Brian R. Edlin publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Brian R. Edlin sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 111 publications — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Brian R. Edlin D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Brian R. Edlin sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 48 D-Index — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Brian R. Edlin is affiliated with the National Development and Research Institutes in the United States. Their research primarily focuses on medicine, with an emphasis on epidemiology and hepatology. The scientist's published work also spans public health, infectious diseases, and genetics.

Their recent papers include:

  • Accessible Hepatitis C Care for People Who Inject Drugs, 2022, JAMA Internal Medicine
  • Human Immunodeficiency Virus and Hepatitis C Virus Infection Testing Among Commercially Insured Persons Who Inject Drugs, United States, 2010-2017, 2020, The Journal of Infectious Diseases
  • Prescription opioid injection among young people who inject drugs in New York City: a mixed-methods description and associations with hepatitis C virus infection and overdose, 2020, Harm Reduction Journal
  • Trans-ancestral fine-mapping of MHC reveals key amino acids associated with spontaneous clearance of hepatitis C in HLA-DQβ1, 2022, The American Journal of Human Genetics
  • Effectiveness of naloxone distribution in community settings to reduce opioid overdose deaths among people who use drugs: a systematic review and meta-analysis, 2025, BMC Public Health

Frequent co-authors collaborating with Brian R. Edlin include:

  • Ana Valencia
  • Candelaria Vergara
  • Chloe L. Thio
  • Andrea L. Cox
  • Eric O. Johnson

The scientist's work has been published notably in the following venues:

  • The Journal of Infectious Diseases
  • Genes and Immunity
  • JAMA Internal Medicine
  • The American Journal of Human Genetics
  • BMC Public Health

The main fields of study for Brian R. Edlin are medicine with a specialization in:

  • Epidemiology
  • Hepatology
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases
  • Genetics

The primary focus of their research revolves around specific topics as follows:

  • Hepatitis C virus research
  • HIV, Drug Use, Sexual Risk
  • Hepatitis B Virus Studies
  • Opioid Use Disorder Treatment
  • Liver Disease Diagnosis and Treatment
  • HIV/AIDS Research and Interventions
  • Diabetes and associated disorders

Best Publications

  • An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome.

    Brian R. Edlin;Jerome I. Tokars;Michael H. Grieco;Jack T. Crawford

  • A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus

    Ludmila Prokunina-Olsson;Brian Muchmore;Wei Tang;Ruth M Pfeiffer

  • Intersecting Epidemics -- Crack Cocaine Use and HIV Infection among Inner-City Young Adults

    Brian R. Edlin;Kathleen L. Irwin;Sairus Faruque;Clyde B. McCoy

  • USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus

    David Lanier;Neil Schram;Ellen Cooper;Kenneth A. Freedberg

  • Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013-2016

    Megan G. Hofmeister;Elizabeth M. Rosenthal;Laurie K. Barker;Eli S. Rosenberg

  • Toward a more accurate estimate of the prevalence of hepatitis C in the United States

    Brian R. Edlin;Brian R. Edlin;Benjamin J. Eckhardt;Marla A. Shu;Scott D. Holmberg

  • Sexual Transmission of HIV-1 Among Injection Drug Users in San Francisco, USA: Risk-Factor Analysis

    Alex H Kral;Ricky N Bluthenthal;Jennifer Lorvick;Lauren Gee

  • NATURALLY OCCURRING DOMINANT RESISTANCE MUTATIONS TO HEPATITIS C VIRUS PROTEASE AND POLYMERASE INHIBITORS IN TREATMENT-NAIVE PATIENTS

    Thomas Kuntzen;Joerg Timm;Andrew Berical;Niall Lennon

  • High Prevalence of Abscesses and Cellulitis Among Community-Recruited Injection Drug Users in San Francisco

    Ingrid A. Binswanger;Alex H. Kral;Ricky N. Bluthenthal;Ricky N. Bluthenthal;Daniel J. Rybold

  • Risk Factors for Skin and Soft-Tissue Abscesses among Injection Drug Users: A Case-Control Study

    Edward L. Murphy;Deborah DeVita;Hui Liu;Eric Vittinghoff

  • Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?

    Brian R. Edlin;Karen H. Seal;Jennifer Lorvick;Alex H. Kral

  • Tuberculosis in Patients Infected with Human Immunodeficiency Virus: Perspective on the Past Decade

    Robert W. Shafer;Brian R. Edlin

  • The effect of syringe exchange use on high-risk injection drug users: a cohort study.

    Ricky N. Bluthenthal;Alex H. Kral;Lauren Gee;Elizabeth A. Erringer

  • Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users.

    Brian R. Edlin;Thomas F. Kresina;Daniel B. Raymond;Michael R. Carden

  • Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts

    Priya Duggal;Chloe L. Thio;Genevieve L. Wojcik;James J. Goedert

  • Origins of Community Strains of Methicillin-Resistant Staphylococcus aureus

    Edwin D. Charlebois;Françoise Perdreau-Remington;Barry Kreiswirth;David R. Bangsberg

  • Spontaneous Clearance of Chronic Hepatitis C Virus Infection Is Associated With Appearance of Neutralizing Antibodies and Reversal of T-Cell Exhaustion

    Sukanya Raghuraman;Heiyoung Park;William O. Osburn;Emily Winkelstein

  • A randomized trial of pegylated interferon alpha-2b plus ribavirin in the retreatment of chronic hepatitis C.

    Ira M Jacobson;Stevan A Gonzalez;Furqaan Ahmed;Edward Lebovics

  • The high-risk sexual practices of crack-smoking sex workers recruited from the streets of three American cities

    Diana Jones;Kathleen Irwin;James Inciardi;Benjamin Bowser

  • Prevalence and duration of hepatitis C among injection drug users in San Francisco, Calif.

    Jennifer Lorvick;Alex H. Kral;Karen Seal;Lauren Gee

  • A randomized controlled trial of monetary incentives vs. outreach to enhance adherence to the hepatitis B vaccine series among injection drug users

    Karen H. Seal;Alex H. Kral;Jennifer Lorvick;Alex McNees

  • High-risk sex behavior among young street-recruited crack cocaine smokers in three American cities: an interim report. The Multicenter Crack Cocaine and HIV Infection Study Team

    B R Edlin;K L Irwin;D D Ludwig;H V McCoy

  • Testing Strategy To Identify Cases of Acute Hepatitis C Virus (HCV) Infection and To Project HCV Incidence Rates

    Kimberly Page-Shafer;Brandee L. Pappalardo;Leslie H. Tobler;Bruce H. Phelps

Frequent Co-Authors

Alex H. Kral
Alex H. Kral RTI International
Michael P. Busch
Michael P. Busch University of California, San Francisco
Thomas R. O'Brien
Thomas R. O'Brien National Institutes of Health
Ricky N. Bluthenthal
Ricky N. Bluthenthal University of Southern California
David L. Thomas
David L. Thomas Johns Hopkins University
Ruth M. Pfeiffer
Ruth M. Pfeiffer National Institutes of Health
Gregory D. Kirk
Gregory D. Kirk Johns Hopkins University
Andrew H. Talal
Andrew H. Talal University at Buffalo, State University of New York
Ira M. Jacobson
Ira M. Jacobson New York University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Microbiology, exploring related online degrees can open doors to diverse and rewarding career paths. For example, becoming a child life specialist involves understanding developmental biology and healthcare environments, which aligns well with a microbiology background.

Additionally, individuals with unique challenges may find options like the best degree for felons useful, as many programs offer flexible online formats and support for non-traditional students.

Microbiology knowledge is also beneficial for healthcare roles, such as becoming a functional medicine nurse. This career combines scientific understanding with patient care and alternative health practices.

Moreover, careers like medical coding provide valuable opportunities in the healthcare sector. Learning about the cpc medical coding salary and career pathways can help microbiology graduates transition into administrative and data-focused roles within health services.

Best Scientists Citing Brian R. Edlin

Trending Scientists